Polygon Management
Latest statistics and disclosures from Tetragon Partners GP's latest quarterly 13F-HR filing:
- Top 5 stock holdings are PATH, KGEI, WBD, WK, LYFT, and represent 72.00% of Tetragon Partners GP's stock portfolio.
- Added to shares of these 10 stocks: PATH (+$86M), WBD (+$25M), WK (+$6.0M), AXSM, DFTX, SLNO, ACAD, IONS, NKTR, CLDX.
- Started 10 new stock positions in ACAD, AARD, WBD, RLAY, DFTX, IONS, SLNO, RARE, KPTI, TECX.
- Reduced shares in these 8 stocks: RAPT, ANNX, , PRAX, ZVRA, MPLT, AVDL, KGEI.
- Sold out of its positions in FOLD, ZVRA, RAPT, AVDL.
- Tetragon Partners GP was a net buyer of stock by $137M.
- Tetragon Partners GP has $515M in assets under management (AUM), dropping by 8.61%.
- Central Index Key (CIK): 0001515070
Tip: Access up to 7 years of quarterly data
Positions held by Polygon Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Tetragon Partners GP
Tetragon Partners GP holds 34 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Uipath Cl A (PATH) | 54.3 | $280M | +44% | 25M | 11.10 |
|
| Kolibri Global Energy Com New (KGEI) | 7.3 | $38M | 6.8M | 5.49 |
|
|
| Warner Bros Discovery Com Ser A (WBD) | 4.9 | $25M | NEW | 924k | 27.46 |
|
| Workiva Com Cl A (WK) | 2.9 | $15M | +66% | 250k | 59.63 |
|
| Lyft Cl A Com (LYFT) | 2.6 | $13M | 1.0M | 13.30 |
|
|
| Sprinklr Cl A (CXM) | 2.6 | $13M | 2.2M | 6.00 |
|
|
| Autolus Therapeutics Spon Ads (AUTL) | 2.5 | $13M | 9.5M | 1.38 |
|
|
| Celldex Therapeutics Com New (CLDX) | 1.9 | $9.9M | +28% | 312k | 31.72 |
|
| Axsome Therapeutics (AXSM) | 1.8 | $9.3M | +104% | 55k | 169.02 |
|
| Arrowhead Pharmaceuticals (ARWR) | 1.5 | $8.0M | +31% | 127k | 62.70 |
|
| Nektar Therapeutics Com New (NKTR) | 1.4 | $7.4M | +48% | 103k | 71.95 |
|
| Annexon (ANNX) | 1.4 | $7.2M | -36% | 1.3M | 5.54 |
|
| Pharvaris N V (PHVS) | 1.2 | $6.3M | +13% | 222k | 28.25 |
|
| Alkermes SHS (ALKS) | 1.1 | $5.7M | +13% | 160k | 35.36 |
|
| Agios Pharmaceuticals (AGIO) | 1.1 | $5.6M | 165k | 33.83 |
|
|
| Immunovant (IMVT) | 1.1 | $5.4M | +31% | 219k | 24.84 |
|
| Praxis Precision Medicines I Com New (PRAX) | 1.0 | $5.1M | -30% | 16k | 322.19 |
|
| Krystal Biotech (KRYS) | 1.0 | $5.1M | +66% | 20k | 258.32 |
|
| Dyne Therapeutics (DYN) | 0.9 | $4.7M | +4% | 258k | 18.13 |
|
| Amylyx Pharmaceuticals (AMLX) | 0.9 | $4.4M | +16% | 318k | 13.90 |
|
| Mbx Biosciences (MBX) | 0.8 | $4.3M | 146k | 29.85 |
|
|
| Definium Therapeutics Com Shs (DFTX) | 0.7 | $3.8M | NEW | 200k | 18.90 |
|
| Soleno Therapeutics (SLNO) | 0.7 | $3.4M | NEW | 102k | 33.48 |
|
| Harmony Biosciences Hldgs In (HRMY) | 0.6 | $3.3M | +44% | 119k | 28.01 |
|
| Silence Therapeutics Ads (SLN) | 0.6 | $3.3M | +72% | 630k | 5.27 |
|
| ACADIA Pharmaceuticals (ACAD) | 0.6 | $3.2M | NEW | 145k | 22.26 |
|
| Ionis Pharmaceuticals (IONS) | 0.6 | $3.1M | NEW | 42k | 75.09 |
|
| Maplight Therapeutics (MPLT) | 0.4 | $2.3M | -31% | 112k | 20.33 |
|
| Relay Therapeutics (RLAY) | 0.4 | $1.8M | NEW | 182k | 9.95 |
|
| Snowflake Com Shs (SNOW) | 0.3 | $1.5M | 10k | 150.82 |
|
|
| Aardvark Therapeutics (AARD) | 0.2 | $1.2M | NEW | 317k | 3.77 |
|
| Tectonic Therapeutic (TECX) | 0.2 | $1.2M | NEW | 38k | 30.91 |
|
| Ultragenyx Pharmaceutical (RARE) | 0.2 | $827k | NEW | 40k | 20.95 |
|
| Karyopharm Therapeutics Com New (KPTI) | 0.1 | $574k | NEW | 103k | 5.57 |
|
Past Filings by Tetragon Partners GP
SEC 13F filings are viewable for Tetragon Partners GP going back to 2012
- Tetragon Partners GP 2026 Q1 filed May 15, 2026
- Tetragon Partners GP 2025 Q4 filed Feb. 17, 2026
- TFG Asset Management GP 2025 Q3 filed Nov. 14, 2025
- TFG Asset Management GP 2025 Q2 filed Aug. 14, 2025
- TFG Asset Management GP 2025 Q1 filed May 15, 2025
- TFG Asset Management GP 2024 Q4 restated filed Feb. 21, 2025
- TFG Asset Management GP 2024 Q4 filed Feb. 14, 2025
- TFG Asset Management GP 2024 Q3 filed Nov. 14, 2024
- TFG Asset Management GP 2024 Q2 filed Aug. 14, 2024
- TFG Asset Management GP 2024 Q1 filed May 15, 2024
- TFG Asset Management GP 2023 Q4 filed Feb. 14, 2024
- TFG Asset Management GP 2023 Q3 filed Nov. 14, 2023
- TFG Asset Management GP 2023 Q2 filed Aug. 14, 2023
- TFG Asset Management GP 2023 Q1 filed May 15, 2023
- TFG Asset Management GP 2022 Q4 filed Feb. 14, 2023
- TFG Asset Management GP 2022 Q3 filed Nov. 14, 2022